The Impact of Prothrombin Complex Concentrate on the Anticoagulatory Effects of Edoxaban

Trial Profile

The Impact of Prothrombin Complex Concentrate on the Anticoagulatory Effects of Edoxaban

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Aug 2016

At a glance

  • Drugs Edoxaban (Primary) ; Prothrombin complex concentrate
  • Indications Embolism; Stroke; Venous thromboembolism
  • Focus Pharmacodynamics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 16 Aug 2016 Results of this and two other studies published in the British Journal of Clinical Pharmacology.
    • 15 Apr 2014 New trial record
    • 29 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top